Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA

Nazli Janjua, Katja E. Wartenberg, Philip M. Meyers, Stephan A. Mayer

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Introduction: Widespread use of intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke is limited by multiple contraindications to its use. Case report: This article describes a patient with stuttering symptoms of pontine ischemia caused by vertebrobasilar dissection who suddenly deteriorated into a locked-in state 32 hours after symptom onset. The quadriparesis was successfully reversed within 3 hours of onset with the combination of pharmacologically induced hypertension, anticoagulation, and intravenous t-PA. Discussion: Even in the face of numerous contraindications (including hypertension, anticoagulation, and treatment beyond 3 hours of symptom onset), intravenous t-PA can be used successfully in carefully selected cases.

Original languageEnglish
Pages (from-to)296-299
Number of pages4
JournalNeurocritical Care
Volume2
Issue number3
DOIs
StatePublished - Jun 2005
Externally publishedYes

Keywords

  • Anticoagulants
  • Basilar artery
  • Dissection
  • Hypertension
  • Locked-in syndrome
  • Thrombolytic therapy
  • Vertebral artery

Fingerprint

Dive into the research topics of 'Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA'. Together they form a unique fingerprint.

Cite this